Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis.

Abstract

While typically considered a pulmonary disease, cystic fibrosis patients develop significant nutritional complications and comorbidities, especially those who are pancreatic insufficient. Clinicians must have a high suspicion for cystic fibrosis among patients with clinical symptoms of pancreatic insufficiency, and pancreatic enzymatic replacement therapy (PERT) must be urgently initiated. PERT presents a myriad of considerations for patients and their supporting dieticians and clinicians, including types of administration, therapy failures, and complications.

• Authors: Peter N Freswick, Elizabeth K Reid, Maria R Mascarenhas
• Journal: Nutrients (Nutrients) Vol. 14 Issue 7 (Mar 23 2022) ISSN: 2072-6643 [Electronic] Switzerland
• PMID: 35405954 (Publication Type: Journal Article, Review)

Topics

• Cystic Fibrosis (complications, drug therapy)
• Enzyme Replacement Therapy
• Exocrine Pancreatic Insufficiency (complications, etiology)
• Humans
• Pancreas
• Pancreatic Diseases (complications)